Fortrea Holdings Inc
NASDAQ:FTRE
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
16.82
40.28
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one FTRE stock under the Base Case scenario is 31.53 USD. Compared to the current market price of 19.73 USD, Fortrea Holdings Inc is Undervalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Fortrea Holdings Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for FTRE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Fortrea Holdings Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Fortrea Holdings Inc
Balance Sheet Decomposition
Fortrea Holdings Inc
Current Assets | 936.9m |
Cash & Short-Term Investments | 105.3m |
Receivables | 689.1m |
Other Current Assets | 142.5m |
Non-Current Assets | 2.7B |
PP&E | 173.1m |
Intangibles | 2.5B |
Other Non-Current Assets | 95.5m |
Current Liabilities | 795.8m |
Accounts Payable | 137.6m |
Accrued Liabilities | 337.1m |
Other Current Liabilities | 321.1m |
Non-Current Liabilities | 1.4B |
Long-Term Debt | 1.1B |
Other Non-Current Liabilities | 229.9m |
Earnings Waterfall
Fortrea Holdings Inc
Revenue
|
2.8B
USD
|
Cost of Revenue
|
-2.3B
USD
|
Gross Profit
|
513m
USD
|
Operating Expenses
|
-599.9m
USD
|
Operating Income
|
-86.9m
USD
|
Other Expenses
|
-216.4m
USD
|
Net Income
|
-303.3m
USD
|
Free Cash Flow Analysis
Fortrea Holdings Inc
USD | |
Free Cash Flow | USD |
FTRE Profitability Score
Profitability Due Diligence
Fortrea Holdings Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
Score
Fortrea Holdings Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
FTRE Solvency Score
Solvency Due Diligence
Fortrea Holdings Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Score
Fortrea Holdings Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FTRE Price Targets Summary
Fortrea Holdings Inc
According to Wall Street analysts, the average 1-year price target for FTRE is 24.79 USD with a low forecast of 17.17 USD and a high forecast of 31.5 USD.
Dividends
Current shareholder yield for FTRE is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
FTRE Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. The company is headquartered in Durham, North Carolina and currently employs 19,000 full-time employees. The company went IPO on 2023-06-16. The firm is a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions and other enabling services. The Company’s segments include Clinical Services and Enabling Services. The Company’s global solutions include Clinical Development, Clinical Pharmacology, Drug Development Consulting Services, Device and Diagnostic Development, and Full and Functional Service Provider Models, among others. Its Clinical Development solutions include Early: Phase I/II a, Late: Phase II b/III, Real-World Evidence and Post-Approval Studies, Decentralized Clinical Trials, Data Analysis and Reporting, Clinical Trial Project Management and Monitoring, and Patient Safety and Pharmacovigilance. By therapeutic or specialty areas, it has scientific expertise in cardiovascular, cell and gene therapies, dermatology, diabetes and endocrinology, hepatology, infectious disease, and others.
Contact
IPO
Employees
Officers
The intrinsic value of one FTRE stock under the Base Case scenario is 31.53 USD.
Compared to the current market price of 19.73 USD, Fortrea Holdings Inc is Undervalued by 37%.